Introduction
Company name: Pfizer Limited
Address: Ramsgate Road
Sandwich
Kent CT13 9NJ
Telephone: 0845 300 8034 (Out of hours: 01304 616161)
Fax: 01737 332521
Email: UKVetLine@pfizer.com
Website: www.only4vets.co.uk
Pathocef 250 mg Intramammary Suspension
Introduction
Company name: Pfizer Limited
Address: Ramsgate Road
Sandwich
Kent CT13 9NJ
Telephone: 0845 300 8034 (Out of hours: 01304 616161)
Fax: 01737 332521
Email: UKVetLine@pfizer.com
Website: www.only4vets.co.uk
Presentation
Pathocef 250 mg Intramammary Suspension is a sterile white to off-white vegetable oil based suspension containing 250 mg cefoperazone (as the sodium salt) in each 10 ml syringe.
Uses
Pathocef 250 mg Intramammary Suspension is indicated for the single dose treatment of clinical mastitis in lactating cows.
Cefoperazone is a third generation, semi-synthetic cephalosporin antibiotic with a broad spectrum of activity covering both Gram-positive and Gram-negative organisms. As a third generation cephalosporin, cefoperazone in vitro shows greater ability to withstand degradation by beta-lactamase enzymes than do members of the first and second generations.
Clinical mastitis caused by a wide range of organisms including the following pathogens has been shown to respond to treatment with Pathocef Intramammary Suspension: Streptococcus agalactiae; Streptococcus dysgalactiae; Streptococcus uberis; Staphylococcus aureus (including penicillinase producing strains); Escherichia coli; Arcanobacterium (Actinomyces) pyogenes; Pseudomonas aeruginosa; Micrococcus spp.; Klebsiella spp.
Dosage and administration
The contents of one 10 ml syringe should be injected into the infected quarter immediately after milking. Before injection the teat should be thoroughly cleaned and disinfected.
Contra-indications, warnings, etc
Milk for human consumption must not be taken from cows during treatment. Milk must not be taken for human consumption until after 108 hours from the last treatment.
Animals intended for human consumption should not be slaughtered during treatment or until 2 days after last treatment.
Cefoperazone is not compatible with aminoglycoside antibiotics such as streptomycin, neomycin and gentamycin. The simultaneous administration of possibly nephrotoxic drugs may prolong the elimination of cefoperazone.
Operator Warning
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross-reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.
Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure, taking all recommended precautions.
If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention.
Wash hands after use.
Pharmaceutical precautions
Do not store above 25°C. The syringe must only be used once.
Dispose of any unused product and empty syringes in accordance with guidance from your local waste regulation authority.
For animal treatment only.
Keep out of reach of children.
Legal category
POM-V
Packaging Quantities
Cartons of 4 syringes.
Further information
With other milking routines, the basis of the veterinary surgeon's advice should be that milk may be taken for human consumption only after the same period from the last treatment.
Marketing authorisation number
Vm 00057/4077.
Significant Changes
New milk withdrawal period | 16/08/2007 |